← Case indexSNH
Steinhoff International (JSE: SNH)
Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.
| Key Fact | Detail |
|---|---|
| Report | Forensic Short — Closed Case |
| Publication date | April 15, 2024 |
| Issuer | Steinhoff International Holdings N.V. (Dutch parent of South-African retail conglomerate) |
| Ticker | JSE: SNH (also Frankfurt) — both delisted |
| Original short | Viceroy Research — "Steinhoff: A Toxic German Auditing Failure" (December 2017) |
| Headline post-publication events | Jooste resigns (Dec 6, 2017); equity collapse from ~R55 to under R5 in days; PwC forensic investigation confirms €7B+ irregularities (2019); Dutch WHOA restructuring (2023); shareholders vote 99% to dissolve and delist (July 2023); JSE and Frankfurt delisting (Oct 2023); Jooste dies (March 2024) |
| Rating | SHORT — Closed Case |
Why We Are Publishing Today
Steinhoff International is the largest confirmed corporate-accounting fraud in modern European listed-company history. Viceroy Research's December 2017 report — coinciding with the publication of an opinion piece in manager magazin and German prosecutor activity — catalyzed the December 6, 2017 resignation of CEO Markus Jooste and the immediate collapse of the equity. The six years between that catalyst and the July 2023 shareholder vote to dissolve constitute one of the most-studied corporate-restructuring sequences in European capital markets.
Section 1 — The Viceroy Thesis (December 2017)
Viceroy Research's report — published the same week as the manager magazin opinion piece and as German prosecutors confirmed an ongoing investigation — alleged that Steinhoff:
- Used a network of off-balance-sheet entities controlled by associated parties to inflate reported income through round-tripped transactions;
- Recorded acquisitions through structures designed to obscure the substance of the consideration and the identity of the counterparty;
- Was led by senior executives, including Jooste, whose personal financial relationships with the off-balance-sheet network were not disclosed.
Viceroy disclosed a short position. Steinhoff's same-week response was largely overtaken by Jooste's resignation and the company's own subsequent acknowledgments.
Section 2 — Collapse: December 6, 2017
- December 6, 2017. Markus Jooste resigns as CEO. Steinhoff acknowledges that "accounting irregularities" require investigation. The JSE-listed equity collapses from approximately R55 to under R5 in subsequent trading sessions — a decline of more than 90%.
- December 2017 onward. Christo Wiese, who had served as Chairman and was Steinhoff's largest shareholder, resigns. The board commissions PwC to conduct a forensic investigation.
Section 3 — The PwC Investigation and €7B+ Confirmation
The PwC forensic investigation report — released in summary form in March 2019 — confirmed that:
- A small group of senior executives, supported by external parties, had inflated profit and asset values at Steinhoff over a multi-year period (approximately 2009–2017);
- The cumulative gross effect on previously-reported earnings and net assets was on the order of €6.5 billion to €7.4 billion;
- The mechanism involved off-balance-sheet entities through which transactions were round-tripped to generate the appearance of third-party revenue and gains.
The PwC findings — in their substantive direction, though differing in specific framing — were broadly consistent with the principal allegations of the Viceroy report and the parallel German prosecutor activity.
Section 4 — Restructuring and the Dutch WHOA
Through 2018–2022, Steinhoff:
- Sold or partially-monetized major operating subsidiaries (Pepkor in South Africa, Pepco in Europe, Mattress Firm in the US);
- Settled the principal civil-litigation claims at the parent level, with creditor and shareholder settlements aggregating in the hundreds of millions of euros;
- Negotiated with creditors of the parent for sequential extensions of debt maturities.
In 2023, the parent invoked the Dutch Wet homologatie onderhands akkoord (WHOA) — the Dutch out-of-court restructuring regime — to implement a creditor-led restructuring. Under the WHOA arrangement, creditors agreed to extend the maturity of approximately €10.2 billion of debt from June 2023 to 2026 in exchange for taking effective economic control of the parent.
Section 5 — July 2023 Vote, October 2023 Delisting
- July 2023. Steinhoff shareholders voted approximately 99% in favor of dissolving the company and delisting from the JSE and Frankfurt exchanges.
- October 2023. The JSE and Frankfurt delistings were effected. Common equity in Steinhoff was converted to contingent value rights (CVRs) under which creditors received approximately 80% and shareholders approximately 20% of any residual recovery — with public commentary at the time noting that shareholder CVRs were unlikely to produce material recovery.
- March 2024. Markus Jooste dies (reported as a suicide), shortly after South African authorities announced a step in the criminal-investigation process. The death foreclosed the principal criminal proceeding contemplated at the executive level in South Africa.
Section 6 — Where Things Stand (April 2024) and What Muddy Insights Takes From The Case
As of April 2024:
- Steinhoff International Holdings N.V. is in formal Dutch liquidation; the JSE-listed equity is delisted and replaced by the CVR structure.
- Operating subsidiaries (Pepkor, Pepco) are independently-managed and listed under their own structures.
- The criminal-procedure track relating to Jooste personally is closed by his March 2024 death; ancillary proceedings against other named individuals continued in South Africa and Germany.
What Muddy Insights takes from the Steinhoff case:
- It remains the European reference case for a confirmed accounting fraud at scale. The PwC-confirmed €6.5–€7.4B aggregate effect is, in absolute terms, the largest European listed-issuer accounting irregularity since the Parmalat and Enron-era frame of reference.
- The off-balance-sheet round-trip pattern is reusable as a diagnostic. Where a listed retail conglomerate reports operating-margin trajectories materially superior to direct industry peers and the operating-margin uplift is concentrated in non-core line items (real-estate gains, structured supply-chain transactions, related-party arrangements), the Steinhoff template warrants application.
- Creditor-led WHOA-style restructurings are now an available European tool. The Dutch WHOA path Steinhoff used to implement its creditor-control restructuring has been replicated by other European issuers; Steinhoff established the post-2017 template.
Source Index (selected)
- Viceroy Research, "Steinhoff: A Toxic German Auditing Failure," December 2017.
- manager magazin coverage, December 2017.
- Steinhoff International Holdings N.V. — PricewaterhouseCoopers forensic investigation report (summary), March 2019.
- Steinhoff International Holdings N.V. — Dutch WHOA proceedings and creditor restructuring documentation, 2023.
- Shareholder resolution to dissolve, July 2023; JSE / Frankfurt delisting timeline, October 2023.
- South African authorities — public statements on the Jooste investigation; March 2024 reports.
— Muddy Insights, April 15, 2024.
// More files
- 0282026-10-21CURRCURR · 2026-10-21Currenc Group Inc. (NASDAQ: CURR) — Forensic FileA Charging Order Over The Only Asset That Matters. The Same 100,465 Tranglo Shares Sold For US$400M Are Now Charged To A Judgment Creditor.NOT RATED — Forensic FileNOT RATED — Forensic File
- 0272026-07-21DLXYDLXY · 2026-07-21Delixy Holdings Ltd. (NASDAQ: DLXY) — Forensic Short ReportThe IPO Funded An Exit, Not An Expansion. Dividends Out 4x What The Public Put In.NOT RATED — Research case studyNOT RATED — Research case study
- 0262026-07-15TROOTROO · 2026-07-15TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateThe August 20 Endgame: Winding-Up Exposure, Suspension Mechanics, And A Support Bid Running On FumesSHORT — High convictionSHORT — High conviction
- 0252026-05-15ADANIENTADANIENT · 2026-05-15Adani Enterprises (NSE: ADANIENT)Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.SHORT — UpdateSHORT — Update
- 0242026-05-05TROOTROO · 2026-05-05TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateAuditor Replaced. Lock-Up Eased. Annual Report Past Due.SHORT — High convictionSHORT — High conviction
- 0232026-04-15TRETRE · 2026-04-15Sino-Forest Corporation (TSX: TRE)The founding case of the modern China-short genre — fifteen years on.SHORT — Closed CaseSHORT — Closed Case
- 0222026-03-30BURBUR · 2026-03-30Burford Capital (NYSE/LSE: BUR)Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.NEUTRALNEUTRAL
- 0212026-02-25IEPIEP · 2026-02-25Icahn Enterprises L.P. (NASDAQ: IEP)Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.SHORT — UpdateSHORT — Update
- 0202026-02-01WDIWDI · 2026-02-01Wirecard AG (XETRA: WDI) — Closed-Case RetrospectiveSix years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.SHORT — Closed CaseSHORT — Closed Case
- 0192026-01-15NKLANKLA · 2026-01-15Nikola Corporation (NASDAQ: NKLA)The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.SHORT — Closed CaseSHORT — Closed Case
- 0182025-12-02MAGHMAGH · 2025-12-02Magnitude International Ltd. (NASDAQ: MAGH) — Forensic ShortPenny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.SHORT — High convictionSHORT — High conviction
- 0172025-10-21VRXVRX · 2025-10-21Valeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.SHORT — Closed CaseSHORT — Closed Case
- 0162025-09-01TIOTIO · 2025-09-01Tingo Group (NASDAQ: TIO)Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.SHORT — Closed CaseSHORT — Closed Case
- 0152024-09-15EBIXEBIX · 2024-09-15Ebix, Inc. (NASDAQ: EBIX)Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.SHORT — UpdateSHORT — Update
- 0142024-07-15FFGRPFFGRP · 2024-07-15Folli Follie (ATHEX: FFGRP)QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.SHORT — Closed CaseSHORT — Closed Case
- 0132024-04-01RIDERIDE · 2024-04-01Lordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.SHORT — Closed CaseSHORT — Closed Case
- 0122022-09-15GSXGSX · 2022-09-15GSX Techedu (NYSE: GSX, now Gaotu: GOTU)Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.SHORT — Closed CaseSHORT — Closed Case
- 0112022-05-15EROSEROS · 2022-05-15Eros International / Eros STX Global (NYSE: EROS, formerly)Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.SHORT — Closed CaseSHORT — Closed Case
- 0102021-09-15QPPQPP · 2021-09-15Quindell PLC (LSE AIM: QPP, now Watchstone)Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.SHORT — Closed CaseSHORT — Closed Case
- 0092020-10-15SONGSONG · 2020-10-15Akazoo S.A. (NASDAQ: SONG)QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.SHORT — Closed CaseSHORT — Closed Case
- 0082020-02-15INSYINSY · 2020-02-15Insys Therapeutics (NASDAQ: INSY)Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.SHORT — Closed CaseSHORT — Closed Case
- 0072020-01-15ONON · 2020-01-15Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed CaseAuditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.SHORT — Closed CaseSHORT — Closed Case
- 0062019-01-15N21N21 · 2019-01-15Noble Group (SGX: N21)Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.SHORT — Closed CaseSHORT — Closed Case
- 0052018-01-15NQNQ · 2018-01-15NQ Mobile (NYSE: NQ)Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.SHORT — Closed CaseSHORT — Closed Case
- 0042015-09-15FMCNFMCN · 2015-09-15Focus Media (NASDAQ: FMCN, formerly)Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.SHORT — Counter-CaseSHORT — Counter-Case
- 0032014-08-01GOWGOW · 2014-08-01Let's Gowex (BME MAB: GOW)Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.SHORT — Closed CaseSHORT — Closed Case
- 0022013-12-15CCMECCME · 2013-12-15China MediaExpress Holdings (NASDAQ: CCME)Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.SHORT — Closed CaseSHORT — Closed Case
- 0012013-12-15LFTLFT · 2013-12-15Longtop Financial Technologies (NYSE: LFT)Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.SHORT — Closed CaseSHORT — Closed Case